Fox Run Management, L.L.C. Adma Biologics, Inc. Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 34,306 shares of ADMA stock, worth $682,003. This represents 0.11% of its overall portfolio holdings.
Number of Shares
34,306
Previous 19,117
79.45%
Holding current value
$682,003
Previous $327,000
107.95%
% of portfolio
0.11%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
379Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$371 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$335 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$256 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$227 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$113 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.9B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...